Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial

Posted on by

Lancet Infectious Diseases
Apr 2021 Volume 21 Number 4 p439-578, e67-e109
https://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
Ananda S Bandyopadhyay, et al.
Open Access